# Merit Medical to acquire assets from BD and Bard for $100 million

Merit Medical Systems entered into an Asset Purchase Agreement to acquire a tunneled home drainage catheter product line from C.R. Bard and a soft tissue core needle biopsy product line from BD for $100 million, contingent on the BD-Bard merger closing.

- Type: Acquisition
- Announced: 2017-11-15
- Where: United States
- Value: $100.0M
- Status: announced
- Products: tunneled home drainage catheter, soft tissue core needle biopsy
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Becton Dickinson & Co](https://endata.com/companies/20401.md) (target)
- [C. R. Bard](https://endata.com/companies/23752.md) (target)
- [Merit Medical Systems](https://endata.com/companies/28214.md) (acquirer)

## Sources

- [marketexclusive.com](https://marketexclusive.com/merit-medical-systemsinc-nasdaqmmsi-files-an-8-k-entry-into-a-material-definitive-agreement-3/2017/11/), 2017-11-16: "On November15, 2017, Merit Medical Systems,Inc., a Utah corporation (“Merit”), entered into an Asset Purchase Agreement (the “Purchase Agreement”) with Becton, Dickinson and Company... to which Merit proposes to acquire various assets... for $100 million."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.